Citations

Mayo Clinic

Showing 10 of 108522 citations.

Defects in Mitochondrial Efficiency and H2O2 Emissions in Obese Women Are Restored to a Lean Phenotype With Aerobic Exercise Training
Konopka, Adam R. , Asante, Albert , Lanza, Ian R. , Man, Chiara Dalla , Amols, M., Irving, Brian A. , Robinson, Matthew M. , Johnson, Matthew L. , Amols, Mark H, Cobelli, Claudio , Nair, K. Sreekumaran , Dalla Man, Chiara , Lanza, Ian R , Konopka, Adam R

Diabetes | January 21, 2015 | Volume: 64 | Issue: 6 | Pages: 2104-2115

10.2337/db14-1701 | PMID 25605809 Get It

The notion that mitochondria contribute to obesity-induced insulin resistance is highly debated. Therefore, we determined whether obese (BMI 33 kg/m2), insulin-resistant women with polycystic ovary syndrome had aberrant skeletal muscle mitochondrial physiology compared with lean, insulin-sensitive women (BMI 23 kg/m2). Maximal whole-body and mitochondrial oxygen consumption were not different between obese and lean women. However, obese women exhibited lower mitochondrial coupling and phosphorylation efficiency and elevated mitochondrial H2O2 (mtH2O2) emissions compared with lean women. We further evaluated the impact of 12 weeks of aerobic exercise on obesity-related impairments in insulin sensitivity and mitochondrial energetics in the fasted state and after a high-fat mixed meal. Exercise training reversed obesity-related mitochondrial derangements as evidenced by enhanced mitochondrial bioenergetics efficiency and decreased mtH2O2 production. A concomitant increase in catalase antioxidant activity and decreased DNA oxidative damage indicate improved cellular redox status and a potential mechanism contributing to improved insulin sensitivity. mtH2O2 emissions were refractory to a high-fat meal at baseline, but after exercise, mtH2O2 emissions increased after the meal, which resembles previous findings in lean individuals. We demonstrate that obese women exhibit impaired mitochondrial bioenergetics in the form of decreased efficiency and impaired mtH2O2 emissions, while exercise effectively restores mitochondrial physiology toward that of lean, insulin-sensitive individuals.
Phase III Open-Label Randomized Study of Eribulin Mesylate Versus Capecitabine in Patients With Locally Advanced or Metastatic Breast Cancer Previously Treated With an Anthracycline and a Taxane
Awada, Ahmad , Twelves, Chris, Yelle, Louise, Perez, Edith A. , Velikova, Galina , Olivo, Martin, He, Yi, Dutcus, Corina E. , Cortés, Javier , He, Philip , Kaufman, Peter A. , Olivo, Martin S, Awada, Ahmad , He, Philip , Cortés, J.

Journal of Clinical Oncology | January 21, 2015 | Volume: 33 | Issue: 6 | Pages: 594-601

10.1200/jco.2013.52.4892 | PMID 25605862 Get It

Purpose This phase III randomized trial (ClinicalTrials.gov identifier: NCT00337103) compared eribulin with capecitabine in patients with locally advanced or metastatic breast cancer (MBC). Patients and Methods Women with MBC who had received prior anthracycline- and taxane-based therapy were randomly assigned to receive eribulin or capecitabine as their first-, second-, or third-line chemotherapy for advanced/metastatic disease. Stratification factors were human epidermal growth factor receptor-2 (HER2) status and geographic region. Coprimary end points were overall survival (OS) and progression-free survival (PFS). Results Median OS times for eribulin (n = 554) and capecitabine (n = 548) were 15.9 and 14.5 months, respectively (hazard ratio [HR], 0.88; 95% CI, 0.77 to 1.00; P = .056). Median PFS times for eribulin and capecitabine were 4.1 and 4.2 months, respectively (HR, 1.08; 95% CI, 0.93 to 1.25; P = .30). Objective response rates were 11.0% for eribulin and 11.5% for capecitabine. Global health status and overall quality-of-life scores over time were similar in the treatment arms. Both treatments had manageable safety profiles consistent with their known adverse effects; most adverse events were grade 1 or 2. Conclusion In this phase III study, eribulin was not shown to be superior to capecitabine with regard to OS or PFS.
Long-Term Care Facilities Are Reservoirs for Antimicrobial-Resistant Sequence Type 131 Escherichia coli
Burgess, Mary Jo , Johnson, James R. , Porter, Stephen B. , Johnston, Brian , Clabots, Connie, Lahr, Brian D. , Uhl, James R., Banerjee, Ritu

Open Forum Infectious Diseases | January 21, 2015 | Volume: 2 | Issue: 1 | Pages: No page available

10.1093/ofid/ofv011 | PMID 26034762 Get It

Abstract Background. Emerging data implicate long-term care facilities (LTCFs) as reservoirs of fluoroquinolone-resistant (FQ-R) Escherichia coli of sequence type 131 (ST131). We screened for ST131 among LTCF residents, characterized isolates molecularly, and identified risk factors for colonization. Methods. We conducted a cross-sectional study using a single perianal swab or stool sample per resident in 2 LTCFs in Olmsted County, Minnesota, from April to July 2013. Confirmed FQ-R E. coli isolates underwent polymerase chain reaction-based phylotyping, detection of ST131 and its H30 and H30-Rx subclones, extended virulence genotyping, and pulsed-field gel electrophoresis (PFGE) analysis. Epidemiological data were collected from medical records. Results. Of 133 fecal samples, 33 (25%) yielded FQ-R E. coli, 32 (97%) of which were ST131. The overall proportion with ST131 intestinal colonization was 32 of 133 (24%), which differed by facility: 17 of 41 (42%) in facility 1 vs 15 of 92 (16%) in facility 2 (P = .002). All ST131 isolates represented the H30 subclone, with virulence gene and PFGE profiles resembling those of previously described ST131 clinical isolates. By PFGE, certain isolates clustered both within and across LTCFs. Multivariable predictors of ST131 colonization included inability to sign consent (odds ratio [OR], 4.16 [P = .005]), decubitus ulcer (OR, 4.87 [ P = .04]), and fecal incontinence (OR, 2.59 [P = .06]). Conclusions. Approximately one fourth of LTCF residents carried FQ-R ST131 E. coli resembling ST131 clinical isolates. Pulsed-field gel electrophoresis suggested intra- and interfacility transmission. The identified risk factors suggest that LTCF residents who require increased nursing care are at greatest risk for ST131 colonization, possibly due to healthcare-associated transmission.
Genomic Analysis Reveals That Immune Function Genes Are Strongly Linked to Clinical Outcome in the North Central Cancer Treatment Group N9831 Adjuvant Trastuzumab Trial
Perez, Edith A. , Thompson, E. Aubrey , Anderson, S. Keith , Asmann, Yan W. , Kalari, Krishna R. , Eckel‐Passow, Jeanette E. , Dueck, Amylou C. , Tenner, Kathleen , Jen, Jin, Fan, Jian-Bing, Geiger, Xochiquetzal J., McCullough, Ann E. , Chen, Beiyun, Jenkins, Robert B. , Reinholz, Monica M., Tenner, Kathleen S, Ballman, Karla V. , Sledge, George W. , Winer, Eric P. , Gralow, Julie R. , Dueck, A. C. , Kalari, Krishna R

Journal of Clinical Oncology | January 21, 2015 | Volume: 33 | Issue: 7 | Pages: 701-708

10.1200/jco.2014.57.6298 | PMID 25605861 Get It

Purpose To develop a genomic signature that predicts benefit from trastuzumab in human epidermal growth factor receptor 2–positive breast cancer. Patients and Methods DASL technology was used to quantify mRNA in samples from 1,282 patients enrolled onto the Combination Chemotherapy With or Without Trastuzumab in Treating Women With Breast Cancer (North Central Cancer Treatment Group N9831 [NCCTG-N9831]) adjuvant trastuzumab trial. Cox proportional hazard ratios (HRs), adjusted for significant clinicopathologic risk factors, were used to determine the association of each gene with relapse-free survival (RFS) for 433 patients who received chemotherapy alone (arm A) and 849 patients who received chemotherapy plus trastuzumab (arms B and C). Network and pathway analyses were used to identify key biologic processes linked to RFS. The signature was built by using a voting scheme. Results Network and functional ontology analyses suggested that increased RFS was linked to a subset of immune function genes. A voting scheme model was used to define immune gene enrichment based on the expression of any nine or more of 14 immune function genes at or above the 0.40 quantile for the population. This model was used to identify immune gene–enriched tumors in arm A and arms B and C. Immune gene enrichment was linked to increased RFS in arms B and C (HR, 0.35; 95% CI, 0.22 to 0.55; P < .001), whereas arm B and C patients who did not exhibit immune gene enrichment did not benefit from trastuzumab (HR, 0.89; 95% CI, 0.62 to 1.28; P = .53). Enriched immune function gene expression as defined by our predictive signature was not associated with increased RFS in arm A (HR, 0.90; 95% CI, 0.60 to 1.37; P = .64). Conclusion Increased expression of a subset of immune function genes may provide a means of predicting benefit from adjuvant trastuzumab.
Training labels for hippocampal segmentation based on the EADC‐ADNI harmonized hippocampal protocol
Boccardi, Marina , Bocchetta, Martina , Morency, Félix C., Collins, D. Louis , Nishikawa, Masami, Ganzola, Rossana , Grothe, Michel J. , Redolfi, Alberto , Pievani, Michela , Antelmi, Luigi , Fellgiebel, Andreas , Duchesne, Simon , Jack, Clifford R. , Frisoni, Giovanni B. , Initiative, EADC‐ADNI Working Group on The Harmonized Protocol for Manual Hippocampal Segmentation and for the Alzheimer's Disease Neuroimaging, Boccardi, Marina , Frisoni, Giovanni B. , Wolf, Dominik Georg Friedrich , Matsuda, Hiroshi , Teipel, Stefan Johannes , Initiative, EADC‐ADNI Working Group on The Harmonized Protocol for Manual Hippocampal Segmentation and for the Alzheimer's Disease Neuroimaging, Jack, Clifford R , Grothe, Michel J , Bocchetta, Martina

Alzheimer's & Dementia | January 20, 2015 | Volume: 11 | Issue: 2 | Pages: 175-183

10.1016/j.jalz.2014.12.002 | PMID 25616957 Get It

AbstractBackgroundThe European Alzheimer's Disease Consortium and Alzheimer's Disease Neuroimaging Initiative (ADNI) Harmonized Protocol (HarP) is a Delphi definition of manual hippocampal segmentation from magnetic resonance imaging (MRI) that can be used as the standard of truth to train new tracers, and to validate automated segmentation algorithms. Training requires large and representative data sets of segmented hippocampi. This work aims to produce a set of HarP labels for the proper training and certification of tracers and algorithms.MethodsSixty‐eight 1.5 T and 67 3 T volumetric structural ADNI scans from different subjects, balanced by age, medial temporal atrophy, and scanner manufacturer, were segmented by five qualified HarP tracers whose absolute interrater intraclass correlation coefficients were 0.953 and 0.975 (left and right). Labels were validated as HarP compliant through centralized quality check and correction.ResultsHippocampal volumes (mm3) were as follows: controls: left = 3060 (standard deviation [SD], 502), right = 3120 (SD, 897); mild cognitive impairment (MCI): left = 2596 (SD, 447), right = 2686 (SD, 473); and Alzheimer’s disease (AD): left = 2301 (SD, 492), right = 2445 (SD, 525). Volumes significantly correlated with atrophy severity at Scheltens' scale (Spearman's ρ = <−0.468, P = <.0005).Cerebrospinal fluid spaces (mm3) were as follows: controls: left = 23 (32), right = 25 (25); MCI: left = 15 (13), right = 22 (16); and AD: left = 11 (13), right = 20 (25). Five subjects (3.7%) presented with unusual anatomy.ConclusionsThis work provides reference hippocampal labels for the training and certification of automated segmentation algorithms. The publicly released labels will allow the widespread implementation of the standard segmentation protocol.
CHIP Is an Essential Determinant of Neuronal Mitochondrial Stress Signaling
Palubinsky, Amy M. , Stankowski, Jeannette N. , Kale, Alixandra C. , Codreanu, Simona G. , Singer, Robert J., Liebler, D.C. , Stanwood, Gregg D. , McLaughlin, BethAnn

Antioxidants & Redox Signaling | January 20, 2015 | Volume: 23 | Issue: 6 | Pages: 535-549

10.1089/ars.2014.6102 | PMID 25602369 Get It

Aims: Determine the mechanism by which C-terminus of HSC70-interacting protein (CHIP) induction alters neuronal survival under conditions of mitochondrial stress induced by oxygen glucose deprivation. Results: We report that animals deficient in the E3 ubiquitin ligase, CHIP, have high baseline levels of central nervous system protein oxidation and lipid peroxidation, reduced antioxidant defenses, and decreased energetic status. Stress-associated molecules typically linked to Parkinson's disease such as the mitochondrial kinase, PTEN-inducible putative kinase 1 (PINK1), and another E3 ligase, Parkin, are upregulated in brains from CHIP knockout (KO) animals. Utilizing a novel biotin–avidin capture technique, we found that the oxidation status of Parkin and the mitochondrial fission protein, dynamin-related protein 1 (Drp1), are altered in a CHIP-dependent manner. We also found that following oxygen–glucose deprivation (OGD), the expression of CHIP, PINK1, and the autophagic marker, LC3, increase and there is activation of the redox-sensitive kinase p66 shc . Under conditions of OGD, CHIP relocalizes from the cytosol to mitochondria. Mitochondria from CHIP KO mice have profound impairments in stress response induced by calcium overload, resulting in accelerated permeability transition activity. While CHIP-deficient neurons are morphologically intact, they are more susceptible to OGD consistent with a previously unknown neuroprotective role for CHIP in maintaining mitochondrial homeostasis. Innovation: CHIP relocalization to the mitochondria is essential for the regulation of mitochondrial integrity and neuronal survival following OGD. Conclusions: CHIP is an essential regulator of neuronal bioenergetics and redox tone. Altering the expression of this protein has profound effects on neuronal survival when cells are exposed to OGD. Antioxid. Redox Signal . 23, 535–549.
Synovial Infiltration in Human T Lymphotropic Virus Type I–Associated Adult T Cell Leukemia/Lymphoma
McPhail, Ellen D. , Chowdhary, Vaidehi , Koster, Matthew J. , McPhail, Ellen Darcy

Arthritis & Rheumatology | January 20, 2015 | Volume: 67 | Issue: 4 | Pages: 945-945

10.1002/art.39038 | PMID 25604902 Get It

Identification of Susceptibility Loci in IL6 , RPS9 / LILRB3 , and an Intergenic Locus on Chromosome 21q22 in Takay
Saruhan‐Direskeneli, Güher , Coit, Patrick , Adler, Adam, Aksu, Kenan , Alıbaz-Öner, Fatma , Aydın, Sibel Zehra , Kamalı, Sevil , Carette, Simon , Cuthbertson, David , Hoffman, Gary S., Önen, Fatoş , Akkoç, Nurullah , Koening, Curry L. , Karadağ, Ömer , Kiraz, Sedat , Langford, Carol A. , Maksimowicz‐McKinnon, Kathleen , McAlear, Carol A. , Özbalkan, Zeynep, Ateş, Aşkın , Karaaslan, Yaşar , Düzgün, Nurşen , Özer, Hüseyin , Erken, Eren , Öztürk, Mehmet Akif , Yazıcı, Ayten , Çefle, Ayşe , Onat, Ahmet Mesut , Kısacık, Bünyamin , Kaşifoğlu, Timuçin , Fresko, İzzet , Seo, Philip , Sreih, Antoine G. , Warrington, Kenneth J. , Ytterberg, Steven R. , Çobankara, Veli , Cunninghame‐Graham, Deborah S., Vyse, Timothy J. , Pamuk, Ömer Nuri̇ , Tunç, Şevket Ercan , Dalkılıç, Ediz , Bıçakçıgil, Müge, Yentür, Sibel P., Wren, Jonathan D. , Sawalha, Amr H. , Renauer, Paul A. , Keser, Gökhan , İnanç, Murat , Akar, Servet , Khalidi, Nader , Monach, Paul A. , Pagnoux, Christian , Seyahi, Emire , Merkel, Peter A. , Di̇reskeneli̇, Haner , Warrington, Kenneth J

Arthritis & Rheumatology | January 20, 2015 | Volume: 67 | Issue: 5 | Pages: 1361-1368

10.1002/art.39035 | PMID 25604533 Get It

Objective Takayasu arteritis is a rare large vessel vasculitis with incompletely understood etiology. This study was undertaken to perform the first unbiased genome‐wide association analysis of Takayasu arteritis. Methods Two independent cohorts of patients with Takayasu arteritis from Turkey and North America were included in our study. The Turkish cohort consisted of 559 patients and 489 controls, and the North American cohort consisted of 134 patients and 1,047 controls of European ancestry. Genotyping was performed using the Omni1‐Quad and Omni2.5 genotyping arrays. Genotyping data were subjected to rigorous quality control measures and subsequently analyzed to discover genetic susceptibility loci for Takayasu arteritis. Results We identified genetic susceptibility loci for Takayasu arteritis with a genome‐wide level of significance in IL6 (rs2069837) (odds ratio [OR] 2.07, P = 6.70 × 10 −9 ), RPS9 / LILRB3 (rs11666543) (OR 1.65, P = 2.34 × 10 −8 ), and an intergenic locus on chromosome 21q22 (rs2836878) (OR 1.79, P = 3.62 × 10 −10 ). The genetic susceptibility locus in RPS9 / LILRB3 lies within the leukocyte receptor complex gene cluster on chromosome 19q13.4, and the disease risk variant in this locus correlates with reduced expression of multiple genes including the inhibitory leukocyte immunoglobulin‐like receptor gene LILRB3 ( P = 2.29 × 10 −8 ). In addition, we identified candidate susceptibility genes with suggestive levels of association ( P < 1 × 10 −5 ) with Takayasu arteritis, including PCSK5, LILRA3, PPM1G/NRBP1 , and PTK2B . Conclusion Our findings indicate novel genetic susceptibility loci for Takayasu arteritis and uncover potentially important aspects of the pathophysiology of this form of vasculitis.